P. Guglielmini, A. Serao, S. Zai, P. Piovano, and F. Grosso, “Second-line treatment with Axitinib: an effective and well-tolerated weapon in the therapeutic sequence of clear cell renal cell carcinoma”, Work Paper Public Hlth, vol. 4, no. 1, Jun. 2015.